Familial Partial Lipodystrophy Latest Advances

Find the Latest Research About Familial Partial Lipodystrophy

Last Updated: 02/24/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 334 publications

Lamin A/C regulates lipid metabolism and inflammation: insights from models of familial partial lipodystrophy 2.

Lamin A/C regulates lipid metabolism and inflammation: insights from models of familial partial lipodystrophy 2.

Journal: The Journal of clinical investigation
Published: November 11, 2025

Erratum. Gain of Function NOTCH3 Variants Cause Familial Partial Lipodystrophy Due to Activation of Senescence Pathways. Diabetes 2025;74:427-438.

Erratum. Gain of Function NOTCH3 Variants Cause Familial Partial Lipodystrophy Due to Activation of Senescence Pathways. Diabetes 2025;74:427-438.

Journal: Diabetes
Published: October 28, 2025

Epicardial adipose tissue measurement is an interesting biomarker for cardiovascular health in a case control study of patients with familial partial type 2 lipodystrophy.

Epicardial adipose tissue measurement is an interesting biomarker for cardiovascular health in a case control study of patients with familial partial type 2 lipodystrophy.

Journal: Diabetes & metabolism
Published: October 07, 2025

Metabolic effects of pioglitazone and sodium-glucose cotransporter 2 inhibitors in familial partial lipodystrophy.

Metabolic effects of pioglitazone and sodium-glucose cotransporter 2 inhibitors in familial partial lipodystrophy.

Journal: Acta diabetologica
Published: September 03, 2025

Improvement of severe hypertriglyceridemia in atypical subtype 4 partial lipodystrophy with volanesorsen.

Improvement of severe hypertriglyceridemia in atypical subtype 4 partial lipodystrophy with volanesorsen.

Journal: Journal of clinical lipidology
Published: July 10, 2025

Coincidence of Autoimmune Diabetes Mellitus and Familial Partial Lipodystrophy.

Coincidence of Autoimmune Diabetes Mellitus and Familial Partial Lipodystrophy.

Journal: JCEM case reports
Published: July 08, 2025

Targeting mineralocorticoid receptors to treat metabolic diseases via the adipocyte.

Targeting mineralocorticoid receptors to treat metabolic diseases via the adipocyte.

Journal: Endocrinology
Published: July 07, 2025

Interesting Case of Familial Partial Lipodystrophy Syndrome (Type 6) with LIPE Gene Defect: A Case Report.

Interesting Case of Familial Partial Lipodystrophy Syndrome (Type 6) with LIPE Gene Defect: A Case Report.

Journal: The Journal of the Association of Physicians of India
Published: June 24, 2025

Potential Impact of Parental Origin of Inheritance on the Clinical Presentation of Familial Partial Lipodystrophy Type 2 Syndrome.

Potential Impact of Parental Origin of Inheritance on the Clinical Presentation of Familial Partial Lipodystrophy Type 2 Syndrome.

Journal: Clinical endocrinology
Published: May 21, 2025

Diagnosis and Management of Genetic Lipodystrophy Syndromes and its Implications for Atherosclerosis.

Diagnosis and Management of Genetic Lipodystrophy Syndromes and its Implications for Atherosclerosis.

Journal: Current atherosclerosis reports
Published: April 27, 2025

Heterozygous pathogenic PPARG variants in patients with severe hypertriglyceridemia.

Heterozygous pathogenic PPARG variants in patients with severe hypertriglyceridemia.

Journal: Journal of clinical lipidology
Published: April 22, 2025

Calf skinfold measurements as a diagnostic tool for lipodystrophy syndromes: a cross-sectional study.

Calf skinfold measurements as a diagnostic tool for lipodystrophy syndromes: a cross-sectional study.

Journal: Diabetology & metabolic syndrome
Published: April 16, 2025
Showing 1-12 of 334

Last Updated: 02/24/2026